Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in VIVO

Food and Function

Volumn 3, Issue 6, 2012, Pages 635-642

  Wang, Piwen ^a   Heber, David ^a   Henning, Susanne M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELL LINES; CATECHOL-O-METHYLTRANSFERASE; EPIGALLOCATECHIN GALLATE; GREEN TEA POLYPHENOLS; INTRACELLULAR CONCENTRATION; MULTIDRUG RESISTANCE; PROTEIN EXPRESSIONS; SEVERE COMBINED IMMUNODEFICIENCIES;

ALKYLATION; BIOCHEMISTRY; BIOLOGICAL ORGANS; CELL CULTURE; CELLS; DISEASES; FLAVONOIDS; METHYLATION; PROTEINS;

PHENOLS;

CATECHIN; CATECHOL METHYLTRANSFERASE; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; POLYPHENOL; QUERCETIN;

ANIMAL; ARTICLE; BIOAVAILABILITY; CHEMISTRY; DOWN REGULATION; DRUG EFFECT; ENZYMOLOGY; GENETICS; HUMAN; MALE; METABOLISM; METHYLATION; MOUSE; MOUSE MUTANT; NEOPLASM; TEA; TUMOR CELL LINE; UPREGULATION;

ANIMALS; BIOLOGICAL AVAILABILITY; CATECHIN; CATECHOL O-METHYLTRANSFERASE; CELL LINE, TUMOR; DOWN-REGULATION; HUMANS; MALE; METHYLATION; MICE; MICE, SCID; NEOPLASMS; POLYPHENOLS; QUERCETIN; TEA; UP-REGULATION;

EID: 84862535811     PISSN: 20426496     EISSN: 2042650X     Source Type: Journal    
DOI: 10.1039/c2fo10254d     Document Type: Article

References (37)

1. C. S. Yang, P. Maliakal and X. Meng, Inhibition of carcinogenesis by tea, Annu. Rev. Pharmacol., 2002, 42, 25-54.
2. V. Crespy and G. Williamson, A review of the health effects of green tea catechins in in vivo animal models, J Nutr, 2004, 134, 3431S-3440S.
3. M. Carvalho, C. Jerónimo, P. Valentão, P. B. Andrade and B. M. Silva, Green tea: A promising anticancer agent for renal cell carcinoma, FoodChem., 2010, 122, 49-54.
4. C. S. Yang, S. Sang, J. D. Lambert and M. J. Lee, Bioavailability issues in studying the health effects of plant polyphenols compounds, Mol Nutr Food Res, 2008, 52 Suppl. 1, S139-151.
5. C. S. Yang, X. Wang, G. Lu and S. C. Picinich, Cancer prevention by tea: animal studies, molecular mechanisms and human relevance, Nat. Rev. Cancer, 2009, 9, 429-439.
6. S. M. Henning, J. J. Choo and D. Heber, Nongallated compared with gallated flavan-3-ols in green and black tea are more bioavailable, J Nutr, 2008, 138, 1529S-1534S.
7. M. Inoue-Choi. J. M. Yuan. C, S. Yang, D. J. Van Den Berg, M. J. Lee, Y. T. Gao and M, C. Yu, Genetic Association Between the COMT Genotype and Urinary Levels of Tea Polyphenols and Their Metabolites among Daily Green Tea Drinkers, Int J Mol Epidemiol Genet. 2010, 1, 114-123.
8. P. Wang, W. J. Aronson, M. Huang, Y. Zhang, R. P. Lee, D. Heber and S. M. Henning, Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention, Cancer Prev. Res., 2010, 3, 985-993.
9. K. R. Landis-Piwowar, S. B. Wan. R. A. Wiegand, D. J. Kuhn, T. H. Chan and Q. P. Dou, Methylation suppresses the proteasome-inhibitory function of green tea polyphenols, J. Cell. Physiol., 2007, 213, 252-260.
10. P. Borst, R. Evers, M. Kool and J. Wijnholds, The multidrug resistance protein family, Biochim. Biophys. Acta, Biomembr., 1999, 1461, 347-357.
11. J. Hong, J. D. Lambert, S. H. Lee, P. J. Sinko and C. S. Yang, Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites, Biochem. Biophys. Res. Commun., 2003, 310, 222-227.
12. J. J. van Zanden, H. M. Wortelboer, S. Bijlsma, A. Punt, M. Usta, P. J. Bladeren, I. M. Rietjens and N. H. Cnubben, Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2, Biochem. Pharmacol, 2005, 69, 699-708.
13. M. Nagai, A. H. Conney and B. T. Zhu, Strong inhibitory effects of common tea catechins and bioflavonoids on the O-methylation of catechol estrogens catalyzed by human liver cytosolic catechol-O-methyltransferase. Drug Metab. Dispos., 2004, 32, 497-504.
14. A. Singh, P. S. Naidu and S. K. Kulkarni, Quercetin potentiates L-Dopa reversal of drug-induced catalepsy in rats: possible COMT/MAO inhibition. Pharmacology, 2003, 68, 81-88.
15. K. A. Kim, P. W. Park and J. Y. Park, Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers, Eur. J. Clin. Pharmacol., 2009, 65, 609-614.
16. Z. S. Ma, T. H. Huynh, C. P. Ng, P. T. Do, T. H. Nguyen and H. Huynh, Reduction of CWR22 prostate tumor xenograft growth by combined tamoxifen-quercetin treatment is associated with inhibition of angiogenesis and cellular proliferation, Int J Oncol, 2004, 24, 1297-1304.
17. J. H. Yang, T. C. Hsia, H. M. Kuo, P. D. Chao, C. C. Chou, Y. H. Wei and J. G. Chung, Inhibition of lung cancer cell growthby quercetin glucuronides via G2/M arrest and induction of apoptosis, Drug Metab. Dispos., 2006, 34, 296-304.
18. A. B. Granado-Serrano, M. A. Martin, L. Bravo, L. Goya and S. Ramos, Quercetin modulates NF-kappa B and AP-1/JNK pathways to induce cell death in human hepatoma cells, Nutr. Cancer, 2010, 62, 390-401.
19. G. Y. Yang, J. Liao, C. Li, J. Chung, E. J. Yurkow, C. T. Ho and C. S. Yang, Effect of black and green tea polyphenols on c-jun phosphorylation and H(2)0(2) production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction, Carcinogenesis, 2000, 21, 2035-2039.
20. I. Reenila, P. Tuomainen and P. T. Mannisto, Improved assay of reaction products to quantitate catechol-O-methyltransferase activity by high-performance liquid chromatography with electrochemical detection, J. Chromatogr. Biomed Appl., 1995, 663. 137-142.
21. A. H. Wu, C. C. Tseng, D. Van Den Berg and M. C. Yu, Tea intake, COMT genotype, and breast cancer in Asian-American women, Cancer Res, 2003, 63, 7526-7529.
22. S. Dawling, N. Roodi, R. L. Mernaugh, X. Wang and F. F. Parl, Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms, Cancer Res, 2001, 61, 6716-6722.
23. B. T. Zhu and J. G. Liehr, Inhibition of catechol O-methyltransferase- catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin. Possible role in estradiol-induced tumorigenesis, J. Biol. Chem., 1996, 271, 1357-1363.
24. K. Landis-Piwowar, D. Chen, T. H. Chan and Q. P. Dou, Inhibition of catechol-O-micron-methyltransferase activity in human breast cancer cells enhances the biological effect of the green tea polyphenol (-)-EGCG, Oncol Rep, 2010, 24, 563-569.
25. A. J. Day, F. Mellon, D. Barron, G. Sarrazin, M. R. Morgan and G. Williamson, Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin, Free Radical Res., 2001, 35, 941-952.
26. J. J. van Zanden, H. van der Woude, J. Vaessen, M. Usta, H. M. Wortelboer, N. H. Cnubben and I. M. Rietjens, The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential, Biochem. Pharmacol., 2007, 74, 345-351.
27. M. Roth, B. N. Timmermann and B. Hagenbuch, Interactions of green tea catechins with organic anion-transporting polypeptides, Drug Metab. Dispos., 2011, 39, 920-926.
28. M. Nait Chabane, A. Al Ahmad, J. Peluso, C. D. Muller and G. Ubeaud, Quercetin and naringenin transport across human intestinal Caco-2 cells, J. Pharm. Pharmacol., 2009, 61, 1473-1483.
29. C. Morand, C. Manach, V. Crespy and C. Remesy, Respective bioavailability of quercetin aglycone and its glycosides in a rat model, BioFactors, 2000, 12, 169-174.
30. American Cancer Society. Cancer facts & figures 2011. American Cancer Society, Atlanta, G A, 2011, p 10.
31. American Cancer Society. Global Cancer Facts & Figures 2nd Edition. American Cancer Society, Atlanta, GA, 2011, p3.
32. J. Mackay, A. Jemal, N. Lee, D. Parkin. The Cancer Atlas. American Cancer Society, Atlanta, GA, 2006 Chapter 13: Lung Cancer.
33. I.A. Hakim, H. H. Chow and R. B. Harris, Green tea consumption is associated with decreased DNA damage among GSTM1-positive smokers regardless of their hOGG1 genotype, J Nutr, 2008, 138, 1567S-1571S.
34. J. E. Klaunig, Y. Xu, C. Han, L. M. Kamendulis, J. Chen, C. Heiser, M. S. Gordon and E. R. Mohler, 3rd, The effect of tea consumption on oxidative stress in smokers and nonsmokers, Proc. Soc. Exp. Biol. Med, 1999, 220, 249-254.
35. C. S. Yang, H. Wang, G. X. Li, Z. Yang, F. Guan and H. Jin, Cancer prevention by tea: Evidence from laboratory studies, Pharmacol. Res., 2011, 64, 113-122.
36. K. Boehm, F. Borrelli, E. Ernst, G. Habacher, S. K. Hung, S. Milazzo and M. Horneber, Green tea (Camellia sinensis) for the prevention of cancer, Cochrane Database Syst Rev, 2009, CD005004.
37. J. E. Lee, D. J. Hunter, D. Spiegelman, H. O. Adami, L. Bernstein, P. A. van den Brandt, J. E. Buring, E. Cho, D. English, A. R. Folsom, J. L. Freudenheim, G. G. Gile, E. Giovannucci, P. L. Horn-Ross, M. Leitzmann, J. R. Marshall, S. Mannisto, M. L. McCullough, A. B. Miller, A. S. Parker, P. Pietinen, C. Rodriguez, T. E. Rohan, A. Schatzkin, L. J. Schouten, W. C. Willett, A. Wolk, S. M. Zhang and S. A. Smith-Warner, Intakes of coffee, tea, milk, soda and juice and renal cell cancer in a pooled analysis of 13 prospective studies, Int. J. Cancer, 2007, 121, 2246-2253.